サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1247443

薬剤管理の世界市場-2023-2030

Global Medication Management Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 200 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
薬剤管理の世界市場-2023-2030
出版日: 2023年03月28日
発行: DataM Intelligence
ページ情報: 英文 200 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

世界の薬剤管理の市場規模は、2022年に24億6,934万米ドルとなり、2030年には101億2,943万米ドルに達すると推定され、予測期間（2023-2030年）に20.00%のCAGRで成長すると予測されています。

薬剤管理とは、患者や介護者とコミュニケーションをとりながら、消費されるすべての薬の正確で徹底したインベントリーを作成する戦略です。完全で正確な処方箋リストは、薬の照合や管理の問題を解決するための第一歩となります。これらのツールは、薬の過剰摂取や過小摂取、飲み忘れ、あるいはアドヒアランスを阻害するその他の重要な状況要因など、患者が薬物関連の有害事象のリスクにさらされる可能性がある行動を特定するのにも役立ちます。

市場力学

世界の薬剤管理市場を牽引する主な要因として、業界参入企業による製品投入が市場の発展を後押ししていること、革新的な技術に資金を投入する病院が増加していること、世界の処方箋枚数の増加に伴い業界が急成長すると予測されていることが挙げられます。

市場参入企業による製品投入が市場の発展を後押ししています。

新製品の発売、ヘルスケアプロセス管理の改善、処方箋エラーの減少に対する投資の増加は、市場拡大の原動力となると予測されています。

例えば、2023年1月、Zhongxin Medical Technology Co.（Ltd.（以下、「中新」）は、当社が一定の契約上の取り決めにより決算を連結している中国の事業体の1つで、がん患者の様々な問題を管理するための「服薬管理支援ミニプログラム」をWeChat上で開始しました（「本プログラム」）。がんやその他の重篤な疾患の患者さんにサービスを提供するプラットフォーム型インターネット技術企業であるZhongchao Inc.が発表したものです。がん患者さんが医薬品の問題をナビゲートし、克服することを支援するために、中新は本プログラムを設立しました。

そして2020年11月、マサチューセッツ州ボストンを拠点とするデジタル治療薬コンパニオンプラットフォームMedisafeは、革新的なMedisafe Maestroプラットフォームの即時実装を発表しました。この最先端のシステムは、デジタルドラッグコンパニオンで提供されるパーソナライズされた患者ケアリソースを作成しながら、正確かつ迅速にペイシェントジャーニーをオーケストレーションするものです。Medisafeは、統合されたCare Connectorを通じて製薬業界にデジタル患者ケアリソースを提供し、リアルタイムの患者参加とパーソナライズされたデジタルドラッグコンパニオンを実現させます。

認知度の低さが市場成長の妨げになると予想されます。

しかし、薬物管理システム市場の成長を阻害するその他の要因としては、低開発国におけるこのようなシステムの認知度の低さや、このようなシステムに関するコストの高さが挙げられます。

COVID-19影響度分析

COVID-19のパンデミックは、経済に好影響を与えました。パンデミックの結果、世界中の医療施設は大きなストレスを受けています。病気の蔓延を避けるため、施錠や社会的隔離が実施されました。日常的な治療や薬の配布のために医療施設にアクセスできない慢性疾患の患者さんたちは苦しんでいました。小売薬局のおかげで、これらの人々は迅速かつ容易に助けを得ることができます。地域薬剤師は、COVID-19パンデミック時に薬物療法を提供する際に、自分の施設を訪れる顧客の薬物療法上の問題を予防し、特定し、解決することに専念します。

地域薬剤師は、COVID-19パンデミック時に最も親しみやすいヘルスケア専門家グループであるため、このポジションに適しているのです。地域薬剤師は、不適切な薬物使用の深刻な問題に対処し、一般市民や慢性疾患患者のような特別な集団に対して、合理的な薬物使用を促進することができます。パンデミックの間、地域薬剤師がこれらのセンターの慢性的な健康状態の管理と服薬アドヒアランスの促進に参加することは、世界の過労のヘルスケアシステムに対する圧力を緩和する上で極めて重要でした。

目次

第1章 調査手法とスコープ

  • 調査手法
  • 調査目的および調査範囲について

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場影響要因
    • 促進要因
      • 市場参入企業別製品投入が市場開拓の一助となっています
      • 革新的な技術に多くの資金を投入する病院が増加していること
    • 阻害要因：
      • 認知度の低さが市場成長の妨げになると予想されます
    • 機会
    • 影響度分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格アナリシス
  • レギュラトリー・アナリシス

第6章 COVID-19の分析

  • 市場におけるCOVID-19の分析
    • COVID-19の市場シナリオの前に
    • 現在のCOVID-19の市場シナリオ
    • COVID-19以降または将来シナリオ
  • COVID-19の中での価格・ダイナミクス
  • 需給スペクトル
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的な取り組み
  • 結論

第7章 ソフトウェアタイプ別

  • コンピューターオーダーエントリー（CPOE）
    • 臨床判断支援システム（CDSS）
    • 電子薬物投与記録
    • 在庫管理システム
    • その他

第8章 サービス別

  • メディケーション・アナリティック・サービス
  • ADEサーベイランスサービス
  • Point of Care Verificationサービス

第9章 配送形態別

  • ウェブベース
  • クラウドベース
  • オンプレミス

第10章 エンドユーザー別

  • 病院
  • 薬局
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • U.K.
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第12章 競合情勢

  • 主な発展と戦略
  • 企業シェア分析
  • 製品ベンチマーキング
  • 注目の主要企業一覧

第13章 企業プロファイル

  • GE Healthcare
    • 会社概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • QUALCOMM Incorporated
  • Omnicell, Inc
  • Talyst, LLC
  • Allscripts Healthcare Solutions Inc.
  • ARxIUM
  • Becton Dickinson and Company
  • Cerner Corporation
  • QuadraMed Affinity Corporation
  • McKesson Corporation

第14章 世界の薬剤管理市場-DataM

目次
Product Code: HCIT1783

Market Overview

The global medication management market size was valued at US$ 2,469.34 million in 2022 and is estimated to reach US$ 10,129.43 million by 2030, growing at a CAGR of 20.00% during the forecast period (2023-2030).

Medication management is a strategy for communicating with patients and caregivers to create a precise and thorough inventory of all the medications consumed. A complete and accurate prescription list is the first step in solving medication reconciliation and management problems. These tools can also help identify behaviors that may put patients at risk for drug-related adverse events, such as overdosing or underdosing on medications, forgetting to take them, or other important contextual factors that impede adherence.

Market Dynamics

The major factors driving the global Medication management market the product launches by industry participants are aiding the market to develop, the growing number of hospitals putting more money into innovative technology and the industry is anticipated to grow quickly as the number of prescriptions worldwide increases.

Product launches by industry participants are aiding the market's growth.

Increased investments in the launch of new products, improved healthcare process management, and reduced prescription error is predicted to drive market expansion.

For instance, in January 2023, Zhongxin Medical Technology Co., Ltd. ("Zhongxin"), one of the China operating entities with which the Company consolidates the financial results through certain contractual arrangements, launched the Medication Management Assistance Mini Program on WeChat (the "Program") to help cancer patients manage a variety of issues. Zhongchao Inc., a platform-based internet technology company that provides services to patients with oncology and other serious diseases, made the announcement. To help cancer patients navigate and overcome pharmaceutical problems, Zhongxin established the Program.

And in November 2020, the Boston, Massachusetts-based digital therapeutics companion platform Medisafe has announced the immediate implementation of its innovative Medisafe Maestro platform. This state-of-the-art system orchestrates medication adherence journeys with precision and speed while creating personalized patient care resources that are provided via a digital drug companion. Medisafe provides the pharmaceutical industry with digital patient care resources through its integrated Care Connector, which results in real-time patient involvement and personalized digital drug companions.

Lack of awareness is expected to hamper the market's growth.

However, other factors impeding the growth of the medication management system market include limited awareness of such systems in underdeveloped nations and greater costs related to such systems.

COVID-19 Impact Analysis

The COVID-19 pandemic had a positive impact on the economy. Medical facilities all over the world are under a great deal of stress as a result of the pandemic. To avoid the illness from spreading, lockdowns and social isolation were implemented. Patients with chronic illnesses who could not access healthcare facilities for routine treatment and medication distribution suffered. Thanks to retail pharmacies, these people may get help quickly and easily. Community pharmacists will concentrate on preventing, identifying, and resolving drug therapy difficulties for clients coming to their facility when delivering pharmaceutical care during the COVID-19 pandemic.

Because they are the most approachable group of healthcare professionals during the COVID-19 pandemic, community pharmacists are well-suited for this position. They can address the serious problems of inappropriate medication use and promote rational medication use to members of the general public and special populations like patients with chronic illnesses. Community pharmacists' participation in these centers' management of chronic health conditions and promotion of medication adherence during the pandemic was crucial in easing the pressure on the world's overworked healthcare systems.

Segment Analysis

The medication analytic services segment is expected to grow at the fastest CAGR during the forecast period (2022-2030)

The service segment is the highest market holder in the global Medication management market. Data analytics is the practice of examining unprocessed datasets for patterns, conclusions, and process improvements. Analytics in the healthcare industry uses both present and historical data to generate macro and micro insights that support patient and Company decision-making. Due to the leading players, the Medication Analytic Services segment leads the market. The companies introduce new products and make them easily accessible to customers.

For instance, in July 2021, LGM Pharma announced that it would provide pharmaceutical developers, manufacturers, and compounding pharmacies with contract analytical testing and stability services. The business currently provides analytical services as a component of its integrated contract development and manufacturing (CDMO) operations, but it is now making its facilities and staff available as a stand-alone contract service.

Additionally in June 2022, With the help of data analytics and artificial intelligence, MetroMedi, the fastest-growing online pharmacy and e-health and wellness retailer in South India (Hyderabad), has introduced health advisory services for their customers' health and wellbeing. Data analytics can benefit every facet of patient care and operational management in the healthcare industry. It aids in boosting disease prevention, enhancing clinical care delivery, and assessing the efficacy of various treatment methods.

And in January 2023, Amazon is increasing its healthcare business by launching a prescription drug discount program. The retail behemoth announced Tuesday that it would introduce RxPass, a subscription service for Prime subscribers. According to Amazon, customers will pay USD 5 per month to fill as many prescriptions as they require from a list of approximately 50 generic pharmaceuticals, which are typically less expensive equivalents of name-brand drugs.

Geographical Analysis

North America holds the largest market share in the global Medication management market.

North America dominates the global Medication management market primarily due to factors like the presence of major companies, the high prevalence of chronic diseases in the area, and the well-established healthcare infrastructure are only a few of the major factors responsible for the market's growth. North America dominates the global medication management market due to the widespread use of IT in healthcare, technological improvements, and the prevalence of infectious and chronic diseases. The increase in prescriptions is one of the main factors contributing to the region's dominance.

Contributing variables include multiple small- and medium-sized businesses that offer medication management systems to different hospitals and pharmacies, a high familiarity with new technology, and a need for primary care physicians.

For instance, in March 2022, Hamilton Beach Brands, Inc. and HealthBeacon plc introduced the Smart Sharps Bin Injection Care Management System in the US. The Smart Sharps Bin tracks injection compliance, provides smart medication management reminders, and provides live customer assistance around-the-clock and safe and convenient syringe disposal through the United States Postal Service's approved mail-back Program. Such product launches in the area are likely to support the growth of the medication management system in North America throughout the anticipated time frame.

Competitive Landscape

The Medication management market is moderately competitive with local and global companies' presence. GE Healthcare, QUALCOMM Incorporated, Omnicell, Inc, Talyst, LLC, Allscripts Healthcare Solutions Inc., ARxIUM, Becton Dickinson and Company, Cerner Corporation, QuadraMed Affinity Corporation, McKesson Corporation and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in August 2022, CareDx Inc.,announced the launch of AlloHome, a pan-organ patient monitoring tool that can gather health data while a patient is at home and is accessible on the AlloCare app, has recently been introduced. Patients who use AlloHome get Bluetooth gadgets, such a blood pressure cuff and a glucose meter, that immediately pair with a smart hub in the house. Data is also sent to the patient's AlloCare app.

Omnicell, Inc.

Overview: Omnicell, Inc., a major provider of healthcare technology, has its corporate headquarters in Mountain View, California. In addition to automated solutions for handling prescriptions in hospitals and other healthcare facilities, it also develops software for patient engagement and medication adherence packaging. Under the brand names Omnicell and EnlivenHealth, it sells its products.

Product Portfolio:

Omnicell's Point of Care: Eliminate nurse countbacks with the Controlled Substance Dispenser for greater efficiency and inventory accuracy. Remotely preselect medications directly from the EHR for fast retrieval at Omnicell ADC.

The global Medication management market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Product launches by industry participants are aiding the market to develop.
      • 4.1.1.2. The growing number of hospitals putting more money into innovative technology.
    • 4.1.2. Restraints:
      • 4.1.2.1. Lack of awareness is expected to hamper the market's growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis
  • 5.4 Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Software Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Software Type
    • 7.1.2. Market Attractiveness Index, By Software Type
  • 7.2. Computerized Physician Order Entry (CPOE)
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
    • 7.2.3. Clinical Decision Support System (CDSS)
    • 7.2.4. Electronic Medication Administration Records
    • 7.2.5. Inventory Management System
    • 7.2.6. Others

8. By Service

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
    • 8.1.2. Market Attractiveness Index, By Service
  • 8.2. Medication Analytic Services
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 8.3. ADE Surveillance Services
  • 8.4. Point of Care Verification Services

9. By Mode of Delivery

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 9.1.2. Market Attractiveness Index, By Mode of Delivery
  • 9.2. Web-based
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 9.3. Cloud-based
  • 9.4. On-premise

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 10.3. Pharmacies
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Software Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Software Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Software Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Software Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Software Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Products Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. GE Healthcare
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. QUALCOMM Incorporated
  • 13.3. Omnicell, Inc
  • 13.4. Talyst, LLC
  • 13.5. Allscripts Healthcare Solutions Inc.
  • 13.6. ARxIUM
  • 13.7. Becton Dickinson and Company
  • 13.8. Cerner Corporation
  • 13.9. QuadraMed Affinity Corporation
  • 13.10. McKesson Corporation

LIST NOT EXHAUSTIVE

14. Global Medication management Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Application
  • 14.3. Contact Us